Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2026-03-27

Clinical Trial Update: Antibiofilm Activity of Chitosan Nanoparticles Against Uropathogenic Escherichia Coli

View source ↗

Summary

Clinical trial update indicating chitosan nanoparticles are being studied for antibiofilm activity against uropathogenic Escherichia coli in urinary tract infec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chitosan nanoparticles (Chitosan nanoparticle)

Snippet

Sponsor: Assiut University | Conditions: Urinary Tract Infections (UTIs), Catheter-Associated Urinary Tract Infections (CAUTIs) | Status: NOT_YET_RECRUITING